Identification of distinct epitopes in dipeptidyl peptidase-4 inhibitor–associated bullous pemphigoid
Science Advances · 2025
DOI: 10.1126/sciadv.adv9423 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Shoko Mai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Dipeptidyl-Peptidase IV Inhibitors, Epitopes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Bullous pemphigoid (BP) is a common autoimmune skin disorder caused by autoantibodies targeting BP180. Recent evidence shows that dipeptidyl peptidase-4 inhibitors (DPP4i), used in diabetes management, can induce BP (DPP4i-BP). DPP4i-BP differs from typical BP in its genetic, clinical, and immunological features, but methods to specifically detect DPP4i-BP autoantibodies have been unavailable. This study used enzyme-linked immunosorbent assay with “domain-swapped BP180” proteins to identify autoantibodies in DPP4i-BP, which targeted BP180 regions from the seventh noncollagenous domain to the fourth collagenous domain (NC7-Col4). These epitopes were associated with DPP4i-BP–specific human leukocyte antigen class II peptide epitopes. Notably, the duration of DPP4i intake before BP onset was significantly shorter in patients with anti–NC7-Col4 autoantibodies than those without them. Measuring the autoantibodies enabled the early diagnosis of DPP4i-BP before epitope spreading. Furthermore, anti–NC7-Col4 autoantibodies were detected in some patients with diabetes taking DPP4i without BP, suggesting that these assays may offer potential tools for early identification of at-risk individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
ORCID-Profile: Shoko Mai, Yosuke Mai, Inkin Ujiie, Kentaro Izumi, Ken Natsuga, Wataru Nishie, Hideyuki Ujiie
Zitieren
APA
Mai, S., Mai, Y., Ujiie, I., Izumi, K., Natsuga, K., Nishie, W., & Ujiie, H. (2025). Identification of distinct epitopes in dipeptidyl peptidase-4 inhibitor–associated bullous pemphigoid. Science Advances. https://doi.org/10.1126/sciadv.adv9423
Vancouver
Mai S, Mai Y, Ujiie I, Izumi K, Natsuga K, Nishie W, et al. Identification of distinct epitopes in dipeptidyl peptidase-4 inhibitor–associated bullous pemphigoid. Science Advances. 2025. doi:10.1126/sciadv.adv9423
BibTeX
@article{Mai2025,
author = {Mai, Shoko and Mai, Yosuke and Ujiie, Inkin and Izumi, Kentaro and Natsuga, Ken and Nishie, Wataru and Ujiie, Hideyuki},
title = {Identification of distinct epitopes in dipeptidyl peptidase-4 inhibitor–associated bullous pemphigoid},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adv9423}
}
EUVIMED